Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S0.45
P/E—
Fwd P/E14.14
PEG1.30
52W— – —
RSI—
Target$450.05 (+7.5%)
Beta0.70
Div1.65%
Loading chart…
RSI ()
Loading patterns…
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 61
Overbought · 100
Signal
Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
4Bullish
5Bearish
0Neutral
Key Signals 1
▼ Double Top
Major reversal
2026-07-16 · $381.24
Two peaks ~$431.61 — bearish reversal confirmed
Learn more →
Momentum Signals 8
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
▲ MACD Bullish Crossover
View overlays on the price chart via Overview tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
62%
5/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$450.05
+7.5% upside
Low $393
—
High $492
Consensus
Current price
Wall Street Analyst Ratings
Sort by
| Firm | Rating | Change | Action | Date |
|---|
Profitability
Gross Margin
25.99%Last 12 Months
Operating Margin
4.56%Last 12 Months
Return on Equity
11.13%Last 12 Months
Revenue Growth
1.40%Year over Year
Free Cash Flow
4.31BLast 12 Months
Free Cash Flow Yield
—Last 12 Months
Balance Sheet
Debt / Equity
68.95Most Recent Quarter
Current Ratio
1.52Most Recent Quarter
Cash
37.51BMost Recent Quarter
Total Debt
31.04BMost Recent Quarter
Net Debt
—Most Recent Quarter
How ELV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 90.81B |
| Enterprise Value | 84.48B |
| Trailing P/E | 18.51 |
| Forward P/E | 14.14 |
| PEG Ratio (5yr) | 1.30 |
| Price/Sales (ttm) | 0.45 |
| Price/Book (mrq) | 2.02 |
| EV/Revenue | 0.42 |
| EV/EBITDA | 10.15 |
Share Statistics
| Avg Vol (3m) | 1.33M |
| Shares Outstanding | 216.87M |
| Float | 216.37M |
| % Held by Insiders | 0.19% |
| % Held by Institutions | 94.13% |
| Short Ratio | 6.12 |
| Short % of Float | 2.83% |
Profitability
| Gross Margin | 25.99% |
| Operating Margin (ttm) | 4.56% |
| Profit Margin | 2.47% |
| Return on Assets (ttm) | 3.83% |
| Return on Equity (ttm) | 11.13% |
Income Statement
| Revenue (ttm) | 201.11B |
| Revenue Growth (yoy) | 1.40% |
| Gross Profit (ttm) | 52.27B |
| EBITDA | 8.32B |
| Net Income (ttm) | 4.96B |
| Diluted EPS (ttm) | 22.62 |
| EPS Growth (yoy) | -13.10% |
Balance Sheet
| Total Cash (mrq) | 37.51B |
| Total Debt (mrq) | 31.04B |
| Debt / Equity (mrq) | 68.95 |
| Current Ratio (mrq) | 1.52 |
| Book Value / Share | 206.99 |
| Operating CF (ttm) | 7.46B |
| Free Cash Flow (ttm) | 4.31B |
Trading & Dividends
| Beta (5Y) | 0.70 |
| 50-Day MA | 397.20 |
| 200-Day MA | 360.57 |
| Fwd Dividend Yield | 1.65% |
| Payout Ratio | 30.34% |
Income
Dividend Yield
1.65%Last 12 Months
Annual Rate
6.88Forward
Payout Ratio
30.34%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 30.34%
Monthly Dividends
Ownership Breakdown
Institutional 94.13%
Insider 0.19%
Public 5.7%
Short Interest
2.83% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in ELV in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|